Join
Live feed
·
INSIDERFilingvia Quantisnow
Clearside Biomedical Inc. logo

SEC Form 4: Thorp Clay disposed of 1,406,507 shares and acquired 8,522 shares, increasing direct ownership by 107% to 16,522 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLSD (Clearside Biomedical Inc.) and more on Quantisnow.